
“A Japanese university is to retract a study that touted the effectiveness of a blood pressure drug made by Swiss pharmaceutical giant Novartis because it was based on fabricated data. The move was the latest chapter in a growing scandal over allegations that bogus data were used in a string of Japanese university studies for the drug Valsartan which exaggerated its effectiveness in preventing strokes and angina. On Wednesday, Tokyo’s Jikei University School of Medicine said it would retract research that appeared in respected medical journal The Lancet six years ago.”
http://www.thelocal.ch/20130731/japanese-university-to-retract-novartis-drug-study
Related posts:
Ex-Comptroller General Walker: 'Fiscal Cliff,' Here We Come
Prosecutors Move To Seize Jesse Jackson, Jr.’s Homes
Liberty Reserve founder: I was arrested for not giving FBI source code
Gun sales hit new record, ammo boom to follow
How Wall Street Lawyer Turned Insider Trader Eluded FBI
Brazil Halts Muni Market as Banks Collect $140 Mln Fees
Pentagon to end exclusive deal with RIM’s Blackberry
Investors in Hot IPOs Are Overlooking Some Serious Risks
Pawn Stars Rick Harrison tells how the feds are keeping him from filming on govt land
Inside ‘Liberland,’ the Place of No Taxes Where Crowdfunding Rules
Gold nugget weighing 5.5 kg discovered in Australia
Investors can’t beat the machines: Computer-dominated trading takes over
17% Would Vote to Secede and Form New State
In-Flight Thieves Targeting Airline Travelers’ Carry-On Bags
$1.3 billion flowing through 2012 presidential race